First study of omicron shows Pfizer vaccine may be less effective
Published
The omicron variant of the coronavirus partially evades antibody immunity from two doses of the Pfizer-BioNTech vaccine, according to initial data from South Africa published Tuesday.
#biontech #pfizer #southafrica